Categories
Resources
Your Recalls
Loading...
Get email alerts when new recalls match your interests.
CGMP Deviations: potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA.
The firm was notified by the FDA that they failed to included a shellfish allergen on their ingredient panel.
cGMP Deviations
cGMP deviations: Presence of foreign material (Teflon)introduced at the production level.
Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.
Lack of Processing Control
FDA sample analysis of Biotin 1000mg Lot #1345 showed the product Biotin content to be 0.8% of label claim.
CGMP Deviations: Impurity for N-nitroso-N-methyl-4-aminobutryric Acid (NBMA) detected in active ingredient (API) used to manufacture finished products.
Presence of Foreign Tablet/ Capsule: Product complaint received indicating mix-up of one lisinopril 5mg tablet inside of a 30 mg, 100-count bottle of Lisinopril Tablets.
Defective Delivery System: Out of specification for mechanical peel and shear.
Failed Impurities/Degradation Specification: Presence of unknown impurity observed.